NeuroBo Pharmaceuticals, Inc. (NRBO) Tops Q3 EPS by 2c

NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on NeuroBo Pharmaceuticals, Inc. (NRBO) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
• S&P downgrades Cable One to ’B+’ on weakening broadband outlook